Modern clinical research on psychedelics is generating interesting outcomes in a wide array
of clinical conditions when psychedelic-assisted psychotherapy is delivered to appropriately …

Clinical research on psychedelic-assisted psychotherapy is rapidly advancing in the USA,
with two drugs, psilocybin and MDMA, progressing through a structure of FDA-approved …

Research on psychedelics has seen a recent revival, with many clinical trials focused on
their therapeutic potential to treat a range of mental health conditions. The purpose of this …

Introduction Interest in the use of psychedelic substances for the treatment of mental
disorders is increasing. Processes that may affect therapeutic change are not yet fully …

Psychedelics have shown great promise in modern clinical trials for treating various
psychiatric conditions. As a transdiagnostic treatment that exerts its effects through …

The acute subjective effects of psychedelics are responsive to users' expectations and
surroundings (ie,“set and setting”). Accordingly, a great deal of thought has gone into …

In clinical research settings around the world, renewed investigations are taking place on
the use of psychedelic substances for treating illnesses such as addiction, depression …

Background: Over the last two decades, a number of studies have highlighted the potential
of psychedelic therapy. However, questions remain to what extend these results translate to …

Psychedelic substances are under investigation in several drug development programs.
Controlled clinical trials are providing evidence for safe and effective use of psychedelic …

Research since the 1950s has shown that psychedelic-assisted psychotherapy has had
significant positive effects in reductions of specific clinical symptoms and increases in quality …